<DOC>
	<DOCNO>NCT02157675</DOCNO>
	<brief_summary>This study randomize , double-blind , placebo-controlled , crossover design study healthy subject determine effect polyherbal supplement sign symptom delay onset muscle soreness ( DOMS ) induce eccentric exercise arm .</brief_summary>
	<brief_title>Effects Polyherbal Supplement Signs Symptoms Delayed Onset Muscle Soreness</brief_title>
	<detailed_description>Approximately 30 subject enrol . The study include 19-day treatment period minimum 7-day washout period test product administer . Subjects crossover second 19-day treatment period complete study . Subjects receive test product ( polyherbal capsule placebo capsule ) daily treatment period . Two exercise test session follow 5 day occur study use modify seated arm-curl bench . Muscle strength assess day 5-day exercise test period . Safety assess study collect adverse event ( AEs ) , clinical laboratory data ( serum hematology chemistry ) , vital sign ( blood pressure , pulse , respiration rate , temperature ) .</detailed_description>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<criteria>≥ 18 year age good general health without clinically significant disease , determine medical history , physical examination , urine drug screen body mass index ( BMI ) ≥ 18 ≤ 30 kg/m2 female child bear potential must agree use appropriate birth control method entire study period agree initiate new exercise diet program entire study period agree change current diet exercise program entire study period understand study procedure sign form provide informed consent participate study , authorize release relevant protect health information study investigator agree stretch , utilize ice massage , take antiinflammatory medication ( eg , aspirin , ibuprofen ) , use treatment duration trial . previous history upper extremity injury pain use antiinflammatory medication pain medication begin screen visit study daily use dietary supplement herbal supplement begin screen visit study use immunosuppressive drug biologic product last 12 month ( include steroid [ except inhaled topical dose form ] ) ; antibiotic use , anticoagulant , intraarticular steroid past 3 month significant GI condition would potentially interfere evaluation study product include limited inflammatory bowel disease ( ulcerative colitis Crohn 's ) , history lap band surgery , history perforation stomach intestine , gastroparesis clinically significant renal , hepatic biliary , endocrine ( include diabetes mellitus ) , cardiac , pulmonary , pancreatic , neurologic ( particularly balance neuropathy problem ) , hematologic disorder , significant mental health disorder know allergy sensitivity herbal ingredient test product , olive oil , soy history presence cancer last 5 year ( except basal cell carcinoma skin insitu cervical cancer ) recent history ( within 2 year ) strong potential alcohol substance abuse participation clinical study exposure nonregistered drug product within 30 day prior study report use tobacco product contain nicotine individual condition Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result put person undue risk , include subject bed wheelchairbound physical disability could interfere ability perform exercise assessment include protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Delayed onset muscle soreness</keyword>
	<keyword>Muscle damage</keyword>
	<keyword>Eccentric exercise</keyword>
</DOC>